Post-anastomotic venous stenosis after Optiflow deployment: An unexpected outcome

Authors

Ziad Al Adas, Henry Ford Health
Georges Haddad, Henry Ford HealthFollow
Bhavin C. Patel, Henry Ford HealthFollow
Lalathaksha Kumbar, Henry Ford HealthFollow
Baha Al-Abid, Henry Ford Health
Praveen Balraj, Henry Ford Health
Loay S. Kabbani, Henry Ford HealthFollow

Recommended Citation

Al Adas Z, Haddad G, Patel BC, Kumbar L, Al-Abid B, Balraj P, and Kabbani LS. Post-anastomotic venous stenosis after Optiflow deployment: An unexpected outcome. SAGE Open Med Case Rep 2019; 7:2050313x19851002.

Document Type

Article

Publication Date

1-1-2019

Publication Title

SAGE Open Med Case Rep

Abstract

Arteriovenous fistula failure represents a major cause of hospitalization and a significant economic burden for end-stage renal disease patients on hemodialysis. The Optiflow (Bioconnect Systems Inc., Ambler, PA) is a new device developed to improve arteriovenous fistula outcomes and decrease failure rates by reducing the risk of stenosis and improving maturation rates. This case report describes a 50-year-old male with hypertensive nephropathy on dialysis who had multiple arteriovenous fistula failures in the past. He was scheduled to undergo brachiocephalic fistula construction using the Optiflow device. After 8 months of use, the new fistula developed a peri-anastomotic venous stenosis, just distal to the Optiflow device. To our knowledge, this is the first time such a complication has been reported.

PubMed ID

31210936

Volume

7

First Page

2050313x19851002